A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL OF MEGESTROL-ACETATE AMONG HIGH-RISK PATIENTS WITH RESECTED MALIGNANT-MELANOMA

被引：33

作者：

CREAGAN, ET ^{[1
]}

INGLE, JN ^{[1
]}

SCHUTT, AJ ^{[1
]}

SCHAID, DJ ^{[1
]}

机构：

[1] MAYO CLIN & MAYO FDN, CANC CTR STAT SECT, ROCHESTER, MN 55905 USA

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1989年 / 12卷 / 02期

关键词：

D O I：

10.1097/00000421-198904000-00013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：152 / 155

页数：4

共 20 条

[1]

BODENHAM DC, 1972, ENDOCRINE THERAPY MA

[2] PROGNOSIS OF SKIN MELANOMA WITH REGIONAL NODE METASTASES (STAGE-II) [J].

CASCINELLI, N ;

VAGLINI, M ;

NAVA, M ;

SANTINAMI, M ;

MAROLDA, R ;

ROVINI, D ;

CLEMENTE, C ;

BUFALINO, R ;

MORABITO, A .

JOURNAL OF SURGICAL ONCOLOGY, 1984, 25 (04) :240-247

[3]

COX DR, 1972, J R STAT SOC B, V34, P187

[4] PROGNOSTIC FACTORS FOR PATIENTS WITH CLINICAL STAGE-1 MELANOMA OF INTERMEDIATE THICKNESS (1.51-3.99 MM) - A CONCEPTUAL-MODEL FOR TUMOR-GROWTH AND METASTASIS [J].

DAY, CL ;

MARTIN, C ;

LEW, RA ;

HARRIS, MN ;

KOPF, AW ;

FITZPATRICK, TB ;

HARRIST, TJ ;

GOLOMB, FM ;

POSTEL, A ;

HENNESSEY, P ;

GUMPORT, SL ;

RAKER, JW ;

MALT, RA ;

COSIMI, AB ;

WOOD, WC ;

ROSES, DF ;

GORSTEIN, F ;

RIGEL, D ;

FRIEDMAN, RJ ;

MINTZIS, MM ;

SOBER, AJ .

ANNALS OF SURGERY, 1982, 195 (01) :35-43

[5]

DAY CL, 1981, NEW ENGL J MED, V305, P1155

[6] SPECIFIC ACTIVE IMMUNOTHERAPY DOES NOT PROLONG SURVIVAL IN SURGICALLY TREATED PATIENTS WITH STAGE 2B MALIGNANT-MELANOMA AND MAY PROMOTE EARLY RECURRENCE [J].

HEDLEY, DW ;

MCELWAIN, TJ ;

CURRIE, GA .

BRITISH JOURNAL OF CANCER, 1978, 37 (04) :491-496

[7]

HERSEY P, 1984, AUST NZ J SURG, V54, P303

[8] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[9] ADJUVANT THERAPY OF CUTANEOUS MALIGNANT-MELANOMA - A CRITICAL-REVIEW [J].

KOH, HK ;

SOBER, AJ ;

HARMON, DC ;

LEW, RA ;

CAREY, RW .

MEDICAL AND PEDIATRIC ONCOLOGY, 1985, 13 (05) :244-260

[10]

MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163

← 1 2 →